Analysis of the Use of the Fetal Movement Counting for Prolonged Pregnancy.
COMPTAMAF
2 other identifiers
interventional
278
1 country
1
Brief Summary
Prospective mono-centric randomized open-label study (randomization 1: 1, 2 groups) comparing a group of patients who received conventional information to a group of patients who had been sensitized to a fetal active movement count technique. The study will take place at the University Hospital Center of Saint-Etienne in the gynecology-obstetrics department. An information brochure on the study will be handed over at the end of the term consultation to 41+0 weeks of gestation. After collecting the consent of the patient, the distribution between the two groups will be done by randomization. Thus, for the fetal active movement count group, fetal active movement count education will be proposed during the term consultation with the submission of an information brochure. The "control" group will also receive a simple information pamphlet with, in writing, what patients currently receive orally: definition of active fetal movements, and the need to consult if the patient perceives less movements of her fetus .The principal objective is to compare perinatal morbidity in relation with the sensation of decrease active fetal movements in case of late pregnancy, according to the fact if the patients use or not the AFM's count.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Oct 2019
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 30, 2019
CompletedStudy Start
First participant enrolled
October 3, 2019
CompletedFirst Posted
Study publicly available on registry
October 7, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
April 2, 2022
CompletedApril 12, 2022
August 1, 2021
2.5 years
September 30, 2019
April 11, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The presence of more than 2 criteria of a composite perinatal morbidity score.
The primary outcome will be the presence of more than 2 criteria of a composite perinatal morbidity score: * Fetal heart rate anomaly during childbirth. * Apgar \< 7 at 5 minutes * Cord arterial Ph \< 7.20 * Acute respiratory distress with the need for surveillance in neonatal resuscitation
At the delivery.
Secondary Outcomes (5)
Number of consultations
At the delivery.
Consultation's delay
At the delivery.
Ranking of consultations in 'justified' or 'not justified'
At the delivery.
Mode of labor
At the delivery.
Childbirth
At the delivery.
Study Arms (2)
Control group
ACTIVE COMPARATORPatients who received a classic information.
Educated group
EXPERIMENTALWho have been educated to the active fetal movements count.
Interventions
The team delivers to each patient a unique and standardized information brochure including a definition of fetal active movements, and the need to consult if the patient perceives less the movements of her fetus.
Delayed single and standardized explanatory card on fetal movements (definition, interests of their follow-up, technique of movements on fetuses, table to fill during the follow-up noting the number of active movements physical feelings at 3 times of the day, managing the decrease in the number of active fetal movements).
Eligibility Criteria
You may qualify if:
- Any pregnant woman presenting herself in the Gynecology-obstetrics Department of the hospital of Saint-Etienne during the term consultation at 41 weeks of amenorrhea + 0 day.
- Non pathological Singleton Pregnancy except for balanced gestational diabetes
- Patient affiliated with or entitled to a Social security plan
- Patients who have given their participation agreement and signing the consent
You may not qualify if:
- Woman refusing to participate in the study (lack of consent)
- Non-francophone woman (and / or enable + read french)
- Woman making a maternity change for childbirth (risk of follow-up bias)
- Pathological pregnancy
- Participation to another interventional study.
- Patient subject to legal protection or unable to express consent
- Patient who has already benefited from an awareness of the AFM's account
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Chu Saint-Etienne
Saint-Etienne, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Tiphaine BARJAT, MD
CHU SAINT-ETIENNE
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 30, 2019
First Posted
October 7, 2019
Study Start
October 3, 2019
Primary Completion
March 30, 2022
Study Completion
April 2, 2022
Last Updated
April 12, 2022
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share